According to the latest report by IMARC Group, titled “Biochips Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” provide the global biochips market size reached a value of US$ 22.08 Billion in 2020 and expects the market to grow at a CAGR of 9.3% during 2021-2026. The report provides a detailed analysis of the market by type, application, technology, materials, distribution channel and end user. Also, the report analyzes the market’s competitive landscape.
Base Year: 2020
Forecast Year: 2021-2026
Download free sample of the report: https://www.imarcgroup.com/biochips-market/requestsample
Biochips Market Industry Definition and Application:
Biochips are miniature versions of a laboratory designed for functioning in a biological environment, especially inside living organisms. They contain millions of sensor elements or biosensors that act as microreactors to detect a particular analyte like a protein, DNA, enzyme, or antibody. They can perform thousands of biological reactions in a few seconds for drug discovery, single nucleotide polymorphism genotyping, in-vitro diagnostics, gene expression profiling and agricultural biotechnology.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Biochips Market Trends and Drivers:
The global biochips market is primarily driven by growing investments in the healthcare sector. The onset of the coronavirus disease (COVID-19) pandemic has encouraged several biotechnology and pharmaceutical companies to develop biochips for detecting viral infections and immunological disorders in the human body. Besides this, these chips are widely used in the medical industry to detect cancerous cells in the body and for forming targeted and personalized medicines for cancer treatment. Moreover, several advancements and upgradation in nanotechnology, and extensive research and development (R&D) activities that results in the emergence of digital microfluidic biochips are also providing a positive thrust to the market growth.
Biochips Market Segmentation:
The report has segmented the market on the basis on type, application, technology, materials, distribution channel and end user.
Breakup by Type:
One Hand Mixer
Two Hand Mixer
Breakup by Application:
Breakup by Technology:
Breakup by Materials:
Breakup by Distribution Channel:
Breakup by End User:
Breakup by Region:
North America:( United States, Canada)
Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico,Others)
Middle East and Africa
Browse full report with TOC: https://www.imarcgroup.com/biochips-market
Who are the Major Biochips Market Key players?
The report provides a detailed analysis of the market leaders, including.
Agilent Technologies, Inc., bioMérieux SA, Bio-RAD Laboratories, Inc., CapitalBio Corporation, Dynamic Biosensors GmbH, EMD Millipore Corporation, Fluidigm Corporation, Illumina, Inc., Perkinelmer, Inc., and Thermo Fisher Scientific Inc.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA